It has been a privilege and a pleasure to support nearly all of Andreas’s innovations over the past 15 years. The journey from the early days of innovation to today's MultiClot system is not only a testament to technological excellence but also to the persistence of a vision rooted in clinical relevance and collaboration. This new platform represents more than just technical progress—it reflects the collective wisdom of decades of development, multidisciplinary input, and fro

A recent proof-of-concept study published in Neurol. Int. 2025 has assessed the effectiveness of ClotPro® viscoelastic point-of-care testing in quickly evaluating DOAC activity among acute ischemic stroke patients to assist in intravenous thrombolysis (IVT) decisions. ClotPro® successfully identified 37.5% (15 patients) as having subtherapeutic levels, allowing 7 of them to undergo IVT. This highlights the potential of real-time whole blood hemostatic assessment at the point

Platelet function monitoring is essential for evaluating the effectiveness of P2Y12 inhibitors in patients undergoing intracranial stent...

Approximately one in five patients on DOACs facing bleeding or urgent surgery show no detectable DOAC levels. Notably, the  DOASENSE...

Glad to be back on board for another year. Lets kick things off by checking out this insightful editorial by Tanaka et al on the value...

Check out this insightful editorial by Tanaka et al on the value of #Clotpro and its unique #TPA-test. The Clot-Pro® TPA test helps in...

The #ClotPro is truly in a class of its own in terms of its testing capabilities. https://www.bjanaesthesia.org/article/S0007-0912(23)005...

The #clotpro#TPA-test is a new viscoelastic point-of-care test assay to assess fibrinolytic potential. TPA-test stands for “tissue...

A great case: using #ClotPro to reveal #fibrinolysis resistance indicated by a clot lysis time (LT) on the #TPA-test...

We are always very grateful to our researchers here in Australia who look to our products to help change and improve patient care. Well...

Amazing work by the group here at Liverpool ICU, Sydney Australia, led by Lucy Coupland showing how #ClotPro viscoelastic testing may be...

ClotPro® has additional test options such as the fibrinolysis response test #TPAtest, or monitoring of the presence of direct oral Xa...

The pathophysiology of ARDS is complex and remains incompletely understood. However, it is clear that ARDS is not simply a disease of...

A great editorial on the value of a rapid and user friendly test https://journals.sagepub.com/doi/10.1177/10760296221096422 The DOAC...

Excellent work showing the #ClotPro #RVVtest correlation w/ anti-Xa activity for coagulation monitoring during #vvECMO Conclusions: RVV...

Laboratory nonresponse is defined by tests with #platelet function #multiplate resulting in ongoing platelet aggregation despite therapy...

Excellent talk on VITT and the role of functional testing #Blood2021 and #THANZ pleasing to see #multiplate being recognised as a fast...

Great to see local research in Australia at the Baker Research Institute in Melbourne and Alfred Health using #multiplate to...

Pre-operative platelet reactivity is a strong, independent predictor of bleeding complications after branched endovascular...

A great case report using #multiplate for the evaluation of platelet function testing in a case of a previous healthy patient, admitted...